The prevalence and clinical features of tuberculous peritonitis in CAPD patients in Turkey, report of ten cases from multi-centers.
OBJECTIVE
To determine the rate, risk factors and outcome of Tuberculous Peritonitis (TBP) in patients treated with continuous ambulatory peritoneal dialysis (CAPD) in our units.


METHODS
Retrospectively, we reviewed the medical data of all CAPD patients from 12 centers for TBP, covering the period between 1986 and December 2002.


METHODS
All patients were from 12 renal clinics at tertiary-care university hospitals.


RESULTS
Ten cases of TBP were identified among the CAPD patients in our centers. There were five male and five female patients with a mean age of 37.2 years. None of the patients had tuberculosis history, 6 patients had predominance of PNL. One patient had coincidental bacterial peritonitis. Two patients were successfully treated without the removal of the Tenckhoff catheter.


CONCLUSIONS
TBP in CAPD patients is a very rare complication. In contrast to predominance of lymphocytes in nonuremic patients with tuberculous peritonitis, CAPD patients with tuberculous peritonitis may have predominance of PNL on examination of the peritoneal fluid. Since TBP has high morbidity and mortality, early diagnosis and treatment of disease are extremely important for improving outcome.
Karayaylali
Ibrahim
I
Department of Nephrology, Medical Faculty, Cukurova University, Adana, Turkey. ibrahim.karayaylali@nefroloji.com
Seyrek
Neslihan
N
Akpolat
Tekin
T
Ateş
Kenan
K
Ozener
Cetin
C
Yilmaz
Mehmet Emin
ME
Utas
Cengiz
C
Yavuz
Mahmut
M
Akcicek
Fehmi
F
Arinsoy
s Turgay
sT
Ataman
Rezzan
R
Bozfakioglu
Semra
S
Camsari
Taner
T
Ersoy
Fevzi
F
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D014395:Peritonitis, Tuberculous / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology
D000995:Antitubercular Agents